×
About 328 results

ALLMedicine™ Tractional Retinal Detachment Center

Research & Reviews  115 results

Long-term outcome of a Chinese cohort idiopathic retinitis, vasculitis, aneurysms, and ...
https://doi.org/10.1007/s10792-021-01915-w 10.1016/j.ophtha.2006.11.014 10.1097/00006982-200308000-00022 10.1016/S0002-9394(02)01823-8 10.1136/bjo.2003.023002 10.1038/sj.eye.6700554 10.1038/sj.eye.6701524 10.1038/eye.2014.213 10.1016/j.mehy.2017.10.031 10.1016/j.mehy.2018.01.016 10.1038/eye.1987.68 10.1016/j.ophtha.2018.07.006
International Ophthalmology; Qi Y, Zhang Y et. al.

Jul 15th, 2021 - To evaluate the clinical characteristics and treatment outcomes of idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN) in a cohort of Chinese patients. The clinical history, imaging evaluation, treatment and outcomes of 42 eyes...

Laser photocoagulation for the treatment of bilateral late-onset retinopathy of prematu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183792
Medicine Lin TY, Feng KM et. al.

Jun 5th, 2021 - Retinopathy of prematurity (ROP) is one of the major leading causes of childhood visual morbidity worldwide. Retinal break and traction develop in regressed ROP can further result in rhegmatogenous or tractional retinal detachment years or even de...

Tractional retinal detachment ('crunch' phenomenon) from intravitreal anti-vascular end...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094377
BMJ Case Reports; Bromeo AJ, Veloso A et. al.

Apr 30th, 2021 - Tractional retinal detachment is an uncommon complication of intravitreal anti-vascular endothelial growth factor (VEGF) injection wherein the drug triggers tractional retinal detachment as a result of fibrovascular membrane contraction. We presen...

Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and as...
https://doi.org/10.1016/j.addr.2021.04.007
Advanced Drug Delivery Reviews; Silva M, Peng T et. al.

Apr 16th, 2021 - Diabetic retinopathy is a frequent microvascular complication of diabetes and a major cause of visual impairment. In advanced stages, the abnormal neovascularization can lead to fibrosis and subsequent tractional retinal detachment and blindness. ...

see more →

Clinicaltrials.gov  11 results

Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy
https://clinicaltrials.gov/ct2/show/NCT03660384

May 6th, 2020 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy
https://clinicaltrials.gov/ct2/show/NCT02590094

Mar 20th, 2019 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...

Vitreomacular Interface Abnormalities in Diabetic Retinopathy Using OCT
https://clinicaltrials.gov/ct2/show/NCT03686436

Jan 17th, 2019 - Diabetic retinopathy (DR) is a leading health concern and a major cause of blindness .DR can be complicated by scar tissue formation, macular edema tractional retinal detachment. Optical coherence tomography has found patient with DR has diffuse r...

Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
https://clinicaltrials.gov/ct2/show/NCT00548197

Oct 16th, 2018 - Eligibility criteria: Diabetic tractional retinal detachment-complexity score between 4 and 8 Main outcome measures: best corrected visual acuity-anatomic condition of the retine(re-attachment of the retina)

Internal Limiting Membrane Flap in the Management of Retinal Detachment Due to Paracentral Retinal Breaks
https://clinicaltrials.gov/ct2/show/NCT03707015

Oct 16th, 2018 - This retrospective observational case series includes nine patients received surgery for retinal detachment due to paracentral retinal breaks developed either from primary rhegmatogenous orgin, or secondary iatrogenic retinal breaks after prior me...

see more →

News  5 results

Surgery Equals Drug Treatment for Bleeding in Diabetic Retinopathy
https://www.medscape.com/viewarticle/943374

Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...

Statins Cut Retinopathy Risk in Type 2 Diabetes
https://www.medpagetoday.com/primarycare/diabetes/77360?comment=true

Jan 10th, 2019 - Treatment with statins was associated with a significantly decreased risk of diabetic retinopathy in patients with type 2 diabetes and high cholesterol in a large cohort study from Taiwan. Statin therapy was also associated with a lower need for i...

Promising Therapies for Diabetic Eye Disease on the Way: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/68284

Oct 3rd, 2017 - One expert describes promising strategies for treating diabetic eye disease. A recent study provides new insights into how to prevent tractional retinal detachment from developing or progressing in patients with severe proliferative diabetic retin...

Diabetic Youth Don't Get Screened for Eye Complication
https://www.medpagetoday.com/ophthalmology/generalophthalmology/64073

Mar 23rd, 2017 - Action Points Many youths with type 1 and type 2 diabetes are not being screened for diabetic retinopathy in accordance with current guidelines. Note that sociodemographic factors also played a role in screening patterns, with minority youth repor...

A Review of Anti-VEGF Agents for Proliferative Diabetic Retinopathy
https://www.medscape.com/viewarticle/825295

Abstract and Introduction Abstract Previous research has implicated vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic retinopathy (DR). Although many studies reviewed the use of anti-VEGF for diabetic macular oedema, little...

see more →